设为首页 加入收藏

TOP

BONJESTA (doxylamine succinate and pyridoxine hydrochloride), extended-release tablets(七)
2018-06-27 09:40:43 来源: 作者: 【 】 浏览:7762次 评论:0
ash; Mean ± SD Multiple-Dose (Day 11) Pharmacokinetic Parameters of BONJESTA (given twice daily) in Healthy Premenopausal Adult Women 
 
* Median (range) † Baseline corrected values  
 
BONJESTA 
Mean±SD 
 
 
AUC0-24 
(ng•h/mL)  
 
AUC0-12 
(ng•h/mL)  
 
AUC0-6 
(ng•h/mL)  
 
Cmax 
(ng/mL)  
 
Tmax* 
(h)  
 
Doxylamine 
 N=34 2879.4 ±
696.0 1573.2 ±
406.5 883.6 ±
228.5 173.6 ±
45.5 3.5
(1.0-20.0) 
 
Pyridoxine 
 N=34 80.0 ±
22.7 46.3 ±
15.4 45.3 ±
16.3 48.2 ±
23.7 1.5
(0.3-16.5) 
 
Pyridoxal† 
 N=34 1511.3 ±
300.0 848.1 ±
183.6 647.2 ±
149.6 189.6 ±
48.3 3.0
(2.0-15.0) 
 
Pyridoxal 5′-Phosphate† 
 N=34 1742.3 ±
554.3 831.7 ±
274.5 426.2 ±
144.0 85.9 ±
26.2 15.0
(2.0-24.0) 
 
Food Effect 
 
In a single-dose, crossover clinical trial conducted in 23 healthy, premenopausal women, the administration of a high fat, high calorie meal delayed the absorption of doxylamine, pyridoxine, and pyridoxine metabolites. This delay is associated with lower peak concentrations of doxylamine, pyridoxine, and pyridoxal. The extent of absorption for pyridoxine was decreased.
 
The effect of food on the peak concentration and the extent of absorption of the pyridoxine component is more complex because the pyridoxine metabolites such as pyridoxal, pyridoxamine, pyridoxal 5′-phosphate, and pyridoxamine 5′-phosphate also contribute to the biological activity. Food significantly reduces the bioavailability of pyridoxine, lowering its Cmax and AUC by approximately 67% and 37%, respectively, compared to fasting conditions. Similarly, food significantly reduces pyridoxal Cmax by approximately 46% compared to fasting conditions. In contrast, food did not affect pyridoxal 5′-phosphate Cmax and AUC. 
 
Table 4 – Mean ± SD Pharmacokinetic Parameters of Doxylamine and Pyridoxine Metabolites Following a Single Dose Administration of BONJESTA Under Fed and Fasted Conditions in Healthy Premenopausal Adult Women 
 
* Profile of Subject 20 was excluded † Median (range) ‡ Baseline corrected values  
BONJESTA
N=23 
 AUC0-t (ng•h/mL) AUC0-inf (ng•h/mL) Cmax 
(ng/mL) Tmax*,† 
 (h) T1/2el 
 (h) 
Doxylamine 
Mean±SD Fasted 1273.7 ±
276.2 1321.9 ±
315.5 85.9 ±
10.6 3.5
(2.5-5.5) 11.9 ±
2.2 
Fed 1242.8 ±
254.0 1281.4 ±
282.9 64.5 ±
15.2 6.5
(2.0-24.0) 12.7 ±
2.60 
Pyridoxine 
Mean±SD Fasted 34.7 ±
以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 4 5 6 7 8 9 10 下一页 尾页 7/13/13
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Trospium Chloride Tabs(Trospiu.. 下一篇VASCEPA(icosapent ethyl)Capsules

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位